← Back to Clinical Trials
Recruiting NCT06995638

NCT06995638 Improving Executive Control in Cognitively Healthy Older Adults: the MUltitasking STrategy (MUST) Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06995638
Status Recruiting
Phase
Sponsor Rutgers, The State University of New Jersey
Condition Healthy Aging
Study Type INTERVENTIONAL
Enrollment 130 participants
Start Date 2025-12-10
Primary Completion 2027-12

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
Web-based Cognitive Training (with strategy)Web-based Cognitive Training (without strategy)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 130 participants in total. It began in 2025-12-10 with a primary completion date of 2027-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Developing efficient cognitive intervention for cognitively health older adults is a major public health goal, due to its potential for reducing age-related cognitive decline and Alzheimer's disease/dementia risk. Executive Control is a relevant cognitive target since it declines with aging and is critical for multi-tasking in daily life. The proposed research investigates whether playing a web-based cognitive complex game (the Breakfast Game) impacts cognitive performance in cognitively healthy older adults. To be enrolled in the study, participants will be asked to undergo a cognitive sassessment, health questionnires, and a blood exam. The intervention consist in one educational session on healthy aging, and 10 one-hour cognitive training sessions 2-3 times a week over one month. Participants will be asked to repeat the cognitive assessment within 1-2 weeks after the intervention, and after three months.

Eligibility Criteria

Inclusion Criteria: * Age 60-75 * Adequate English proficiency * Willingness to adhere to training protocol: * Attend 2 in-person assessments * Attend a blood test * Attend online intervention sessions and online follow-up assessment Exclusion Criteria: * Low test scores (below 26 on the Montreal Cognitive Assessment) * Known history of cognitive impairment, dementia, stroke, seizure disorder, or other neuropsychiatric condition judged to impact cognitive performance. * Taking medications known to influence cognitive performance. * Sensory (e.g. visual, auditory) or physical (e.g. severe arthritic, orthopedic, neurologic) impairment incompatible with use of a standard computer workstation. * Enrolled in a concurrent study that could affect the outcome of this study.

Contact & Investigator

Central Contact

Thamiris Golçalves Clinical Research Coordinator, MS

✉ engaging.lab@rutgers.edu

📞 973-972-2977

Principal Investigator

Sharon Sanz Simon Assistant Professor, Ph.D.

PRINCIPAL INVESTIGATOR

Rutgers University

Frequently Asked Questions

Who can join the NCT06995638 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, up to 75 Years, studying Healthy Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06995638 currently recruiting?

Yes, NCT06995638 is actively recruiting participants. Contact the research team at engaging.lab@rutgers.edu for enrollment information.

Where is the NCT06995638 trial being conducted?

This trial is being conducted at Newark, United States.

Who is sponsoring the NCT06995638 clinical trial?

NCT06995638 is sponsored by Rutgers, The State University of New Jersey. The principal investigator is Sharon Sanz Simon Assistant Professor, Ph.D. at Rutgers University. The trial plans to enroll 130 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology